Inactive Instrument

Other languages MDxHealth SA Euronext Bruxelles

Equities

Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering	03-12
MDxHealth SA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	03-06
MDxHealth SA Maintains Earnings Guidance for the Year 2024	03-06
MDxHealth SA Announces Jan Pensaert Steps Down from its Board of Directors	02-16
MDxHealth Preliminary Q4 Revenue Tops Consensus; 2024 Outlook Exceeds Estimates; Shares Jump After Hours	01-08
MDxHealth SA Provides Earnings Guidance for the Fourth Quarter and Full Year 2023 and Year 2024	01-08

No results for this search